AMGN - Amgen Inc.
Stock Analysis
Data: 2026-02-03us_universe.csv
- 2025IPOs.csv
- tb_sch.csv
- test_small.csv
- us_AI.csv
- us_cpu.csv
- us_Nuclear.csv
- us_penny_100.csv
- us_penny.csv
- us_Quantum.csv
- us_universe.csv
Last updated: Feb 03, 2026 at 8:30 PMFresh
show_chart Price & Trend 341.38 • 52W 261.43 - 346.38
Volume
Close
EMA9
MA50
MA150
MA200
Breakout
MA200 Reclaim
MA50 Touch
Pocket Pivot
PB Bounce
EMA9 Cross
auto_graph Pattern Recognition
check_circle
check_circle
Strong pattern recognition: 61% of signals lead to gains within 10 days.
Signal Success Rate
61%
120 total signals
Avg Gain on Winners
+4.8%
73 wins
Avg Loss on Losers
-4.4%
47 losses
Recurring Behaviors
trending_up
Tendency to go on win streaks (longest: 11 signals in a row)
trending_down
Warning: Can experience losing streaks (longest: 10 signals)
rocket_launch
Pullbacks outperform breakouts (84% vs 56% win rate)
Best Signal Type
MA50Touch
15 signals • 87% win rate
Avg gain: +5.2%
Worst Signal Type
MA200Reclaim
16 signals • 44% win rate
Avg loss: -1.7%
All Signal Types (Best ? Worst)
MA50Touch
87%
15 signals
+5.2%
PullbackBounce
81%
16 signals
+3.4%
Breakout
56%
18 signals
+0.4%
PocketPivot
55%
55 signals
+0.6%
MA200Reclaim
44%
16 signals
-1.7%
Trading Insights
lightbulb
Focus on MA50Touch signals - 87% win rate.
Swing Cycle Analysis
Dominant pattern: ±5% every ~2.0 days (strength 0.54)
This stock shows a moderate ±5% swing pattern approximately every 2.0 days, though timing variability reduces reliability.
This stock exhibits a moderate ±5% swing about every ~2.0 days, suggesting upward bias with limited downside troughs and some repeatability but still variable timing.
| Swing | Avg Days | Strength | Pattern? |
|---|---|---|---|
| 5% | 2.0 | 0.54 Moderate | ? |
| 4% | 2.0 | 0.34 Moderate | ? |
| 3% | 2.0 | 0.33 Moderate | ? |
? Trough
? Peak(turning points)
This stock shows a moderate ±5% swing pattern approximately every 2.0 days, though timing variability reduces reliability.
assessment Key Metrics Universe Updated
Price
$341.38
Score
U
0.681
RS 6M
U
71
RS 3M
U
84
description Recommendation Summary
Buy
Confidence: 10/10
Performance: B+ Good
R/C: 0.33:1
BUY (Confidence: 10/10) - Tight Base Breakout (VCP) | Strong Uptrend (Stage 2) | Strong Momentum (Sustained) | R/R 0.33:1 (Risk 4.5%) | Avoid/Extended
Trend
Strong Uptrend (Stage 2)
Momentum
Strong Momentum (Sustained)
Setup Type
Tight Base Breakout (VCP)
grade Absolute Rating
Hold
Standalone Technical Quality
check_circle
Trend Strength (Price > MA50, proper stack) (2 points)
cancel
13W Return ? +20% (0 points)
cancel
4W Return ? +8% (0 points)
check_circle
Up/Down Volume ? 1.10 (1 points)
check_circle
ATR(20) ? 3.5% (1 points)
cancel
Within 5%-25% of 52W High (0 points)
cancel
Risk/Reward ? 2:1 (R/R 0.33:1) (0 points)
Future Analytics
Coming soon...
security Risk Management
Suggested Stop Loss
$325.89
4.5% riskPotential Upside
+1.5%
R/R: 0.3:1Expected Move (20 d, ATR Proxy)
±$27.71 (8.1%)
Range: $313.67 - $369.09insights What It Means
The stock shows a mix of technical characteristics with strong relative strength and a solid composite score. Risk/Reward moderate (~0.3:1); catalysts or consolidation may improve it.
Positives
check_circle
Strong relative strength (RS6M 71, RS3M 84)
check_circle
Perfect moving average stack (healthy uptrend)
check_circle
Accumulation (Up/Down Vol 1.66)
Negatives / Risks
No major technical risksthumb_up Bullish Factors 10
check_circle
Strong 6m RS: 71th percentile
check_circle
Elite 3m RS: 84th percentile (top 16%)
check_circle
Accelerating momentum (3m > 6m RS)
check_circle
Perfect MA stack (MA50 > MA150 > MA200)
check_circle
Price above all major MAs (strong trend)
check_circle
Strong accumulation: 1.66x up/down volume
check_circle
Tight base: 33th percentile ATR (low volatility)
check_circle
Strong 1-week gain: +3.9%
check_circle
Near 52-week high: -1.4% off peak
check_circle
Risk/Reward: 0.33:1 (Risk 4.5%, Reward 1.5% )
thumb_down Bearish Factors 1
cancel
Suboptimal R/R (<1:1)
analytics Technical Indicators
Current Price
$341.38
MA 50
$325.89
4.8%MA 150
$302.30
12.9%MA 200
$297.99
14.6%News & Sentiment
Last updated Feb 03 20:30
Sentiment line (?1..+1) with scaled article volume bars (height relative to sentiment range). Rolling 7d average smooths trend.
Positive day
Negative day
Neutral
Sentiment
7d Avg
Avg 7d: +0.08
Articles 7d: 57
Latest: 0.00 (1)Peak: +0.24 Feb 3
Amgen (AMGN) Surpasses Q4 Expectations, Sets 2026 Guidance - GuruFocus
"AMGN stock" - Google News
Feb 03 4:04 PM
0.00
Amgen (AMGN) Surpasses Q4 Expectations, Sets 2026 Guidance GuruFocus
Amgen Beats Expectations as Top Drugs Boost Sales and Profit - Bloomberg.com
"AMGN stock" - Google News
Feb 03 3:47 PM
+0.30
Amgen Beats Expectations as Top Drugs Boost Sales and Profit Bloomberg.com
Amgen posts Q4 total revenue $9.87 bln vs IBES estimate $9.47 bln - marketscreener.com
"AMGN stock" - Google News
Feb 03 3:36 PM
0.00
Amgen posts Q4 total revenue $9.87 bln vs IBES estimate $9.47 bln marketscreener.com
AMGN: Strong 2025 growth and robust 2026 outlook driven by innovation and portfolio breadth - TradingView
"AMGN stock" - Google News
Feb 03 3:26 PM
+0.20
AMGN: Strong 2025 growth and robust 2026 outlook driven by innovation and portfolio breadth TradingView
Amgen (AMGN) Q4 earnings and revenues beat estimates - MSN
"AMGN stock" - Google News
Feb 03 3:22 PM
+0.10
Amgen (AMGN) Q4 earnings and revenues beat estimates MSN
Amgen (AMGN) Q4 2025 Earnings Call Transcript - The Globe and Mail
"AMGN stock" - Google News
Feb 03 3:11 PM
0.00
Amgen (AMGN) Q4 2025 Earnings Call Transcript The Globe and Mail
Amgen Q4 Earnings Call Highlights - Yahoo Finance
"AMGN stock" - Google News
Feb 03 3:07 PM
0.00
Amgen Q4 Earnings Call Highlights Yahoo Finance
Amgen Inc (NASDAQ:AMGN) Beats Q4 2025 Estimates and Provides Strong 2026 Revenue Guidance - Chartmill
"AMGN stock" - Google News
Feb 03 3:01 PM
+0.30
Amgen Inc (NASDAQ:AMGN) Beats Q4 2025 Estimates and Provides Strong 2026 Revenue Guidance Chartmill
Here's What Key Metrics Tell Us About Amgen (AMGN) Q4 Earnings - Yahoo Finance
"AMGN stock" - Google News
Feb 03 3:00 PM
0.00
Here's What Key Metrics Tell Us About Amgen (AMGN) Q4 Earnings Yahoo Finance
Amgen beats on both lines in Q4 and issues 2026 guidance (AMGN:NASDAQ) - Seeking Alpha
"AMGN stock" - Google News
Feb 03 2:57 PM
+0.20
Amgen beats on both lines in Q4 and issues 2026 guidance (AMGN:NASDAQ) Seeking Alpha
AMGEN ($AMGN) Releases Q4 2025 Earnings - Quiver Quantitative
"AMGN stock" - Google News
Feb 03 2:50 PM
0.00
AMGEN ($AMGN) Releases Q4 2025 Earnings Quiver Quantitative
Amgen (AMGN) Surpasses Q4 Earnings Expectations with Strong Reve - GuruFocus
"AMGN stock" - Google News
Feb 03 2:28 PM
+0.10
Amgen (AMGN) Surpasses Q4 Earnings Expectations with Strong Reve GuruFocus
Stocks making the biggest moves after hours: Chipotle, Advanced Micro Devices, Amgen and more - CNBC
"AMGN stock" - Google News
Feb 03 2:21 PM
0.00
Stocks making the biggest moves after hours: Chipotle, Advanced Micro Devices, Amgen and more CNBC
Amgen Stock Pops As Obesity Fervor Grows - Investor's Business Daily
"AMGN stock" - Google News
Feb 03 2:07 PM
0.00
Amgen Stock Pops As Obesity Fervor Grows Investor's Business Daily
Markets Rotate Back Out of Tech, Q4 Earnings After the Close - Zacks Investment Research
"AMGN stock" - Google News
Feb 03 2:02 PM
-0.10
Markets Rotate Back Out of Tech, Q4 Earnings After the Close Zacks Investment Research
Amgen (NASDAQ:AMGN) Updates FY 2026 Earnings Guidance - MarketBeat
"AMGN stock" - Google News
Feb 03 1:39 PM
+0.10
Amgen (NASDAQ:AMGN) Updates FY 2026 Earnings Guidance MarketBeat
Amgen (NASDAQ:AMGN) Issues Quarterly Earnings Results, Beats Expectations By $0.55 EPS - MarketBeat
"AMGN stock" - Google News
Feb 03 1:21 PM
+0.20
Amgen (NASDAQ:AMGN) Issues Quarterly Earnings Results, Beats Expectations By $0.55 EPS MarketBeat
Amgen Q4 Adjusted Earnings Fall, Revenue Rises; Issues Guidance - marketscreener.com
"AMGN stock" - Google News
Feb 03 1:17 PM
-0.10
Amgen Q4 Adjusted Earnings Fall, Revenue Rises; Issues Guidance marketscreener.com
Amgen (NASDAQ:AMGN) Reports Upbeat Q4 CY2025 - The Globe and Mail
"AMGN stock" - Google News
Feb 03 1:14 PM
+0.10
Amgen (NASDAQ:AMGN) Reports Upbeat Q4 CY2025 The Globe and Mail
Amgen (NASDAQ:AMGN) Reports Upbeat Q4 CY2025 - FinancialContent
"AMGN stock" - Google News
Feb 03 1:13 PM
+0.10
Amgen (NASDAQ:AMGN) Reports Upbeat Q4 CY2025 FinancialContent
Amgen earnings beat by $0.56, revenue topped estimates - Investing.com
"AMGN stock" - Google News
Feb 03 1:09 PM
+0.10
Amgen earnings beat by $0.56, revenue topped estimates Investing.com
(AMGN) Amgen Expects 2026 Revenue Range $37B-$38.4B, vs. FactSet Est of $37.19B - marketscreener.com
"AMGN stock" - Google News
Feb 03 1:02 PM
0.00
(AMGN) Amgen Expects 2026 Revenue Range $37B-$38.4B, vs. FactSet Est of $37.19B marketscreener.com
Amgen (AMGN) Pre-Earnings Options Activity Indicates Market Anti - GuruFocus
"AMGN stock" - Google News
Feb 03 11:58 AM
0.00
Amgen (AMGN) Pre-Earnings Options Activity Indicates Market Anti GuruFocus
Amgen options imply 3.4% move in share price post-earnings - TipRanks
"AMGN stock" - Google News
Feb 03 11:50 AM
0.00
Amgen options imply 3.4% move in share price post-earnings TipRanks
Silver Economy Boom: Investing in Healthcare's Aging Tailwinds - The Globe and Mail
"AMGN stock" - Google News
Feb 03 9:28 AM
0.00
Silver Economy Boom: Investing in Healthcare's Aging Tailwinds The Globe and Mail
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Galecto (GLTO), Roche Holding AG (OtherRHHVF) and Amgen (AMGN) - The Globe and Mail
"AMGN stock" - Google News
Feb 03 5:19 AM
0.00
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Galecto (GLTO), Roche Holding AG (OtherRHHVF) and Amgen (AMGN) The Globe and Mail
Amgen (NASDAQ:AMGN) reports upbeat Q4 CY2025
AMGN stock - BingNews
Feb 03 5:13 AM
+0.10
Biotech company Amgen (NASDAQ:AMGN) reported Q4 CY2025 results , with sales up 8.6% year on year to $9.87 billion. The company’s full-year revenue guidance of $37.7 billion at the midpoint came in 1.8 ...
Jim Cramer on Amgen: "The Biotech Really Impressed Me With a Very Strong Pipeline" - Finviz
"AMGN stock" - Google News
Feb 03 4:43 AM
+0.10
Jim Cramer on Amgen: "The Biotech Really Impressed Me With a Very Strong Pipeline" Finviz
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Galecto (GLTO), Roche Holding AG (OtherRHHVF) and Amgen (AMGN)
AMGN stock - BingNews
Feb 03 2:22 AM
0.00
According to TipRanks.com, Renza is a 5-star analyst with an average return of 23.2% and a 50.2% success rate. Renza covers the Healthcare sector, focusing on stocks such as Ascentage Pharma Group ...
AlphaQuest LLC Makes New Investment in Amgen Inc. $AMGN - MarketBeat
"AMGN stock" - Google News
Feb 03 12:41 AM
+0.10
AlphaQuest LLC Makes New Investment in Amgen Inc. $AMGN MarketBeat
Stock Scanner
- scienceTestingkeyboard_arrow_down
Stock Scanner v1.0.0
Copyright Ⓒ 2025